NCRI 2019: Risk of prostate cancer influenced by levels of two circulating hormones

Prostate cancer represents the second most prevalent male cancer form. Research, presented at the 2019 NCRI Cancer Conference (3–5 November, Glasgow, UK), suggests that elevated circulating levels of free testosterone and IGF-I – a growth hormone – increase men’s risk of being diagnosed with prostate cancer.Certain demographic characteristics – such as age, ethnicity and familial disease history – are known to be associated with individuals’ risk of developing prostate cancer. This study, led by researchers from the University of Oxford (UK), is the first to robustly demonstrate that two blood-circulating factors, whose levels may be modifiable, are associated with prostate...